Vishwanath et al. evaluated 300 patients with type 2 diabetes mellitus (DM), and the levels of IL-6 (p=0.02), hsCRP (p <0.001), and TNF-a (p=0.01) in the YG showed a significant reduction at 12 weeks compared to baseline. This evidence concerns the gene IL6 and diabetes mellitus.